Ferdinando Nicoletti

Active 1985–2025

275
Papers
37,506
Citations
107
h-index
268
i10-index

Citations

Citations per year for Ferdinando Nicoletti1986: 8 citations1987: 39 citations1988: 55 citations1989: 57 citations1990: 53 citations1991: 52 citations1992: 59 citations1993: 34 citations1994: 52 citations1995: 34 citations1996: 55 citations1997: 59 citations1998: 72 citations1999: 117 citations2000: 97 citations2001: 153 citations2002: 135 citations2003: 232 citations2004: 156 citations2005: 198 citations2006: 170 citations2007: 183 citations2008: 228 citations2009: 204 citations2010: 261 citations2011: 289 citations2012: 341 citations2013: 284 citations2014: 304 citations2015: 280 citations2016: 276 citations2017: 268 citations2018: 271 citations2019: 1,072 citations2020: 1,222 citations2021: 1,259 citations2022: 1,190 citations2023: 902 citations2024: 1,514 citations2025: 751 citations2026: 20 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,229 citing papers, 20.9% of this breakdownChina: 1,959 citing papers, 12.6% of this breakdownItaly: 1,236 citing papers, 8% of this breakdownUnited Kingdom: 691 citing papers, 4.5% of this breakdownIndia: 654 citing papers, 4.2% of this breakdownGermany: 641 citing papers, 4.1% of this breakdownFrance: 446 citing papers, 2.9% of this breakdownCanada: 445 citing papers, 2.9% of this breakdownSpain: 386 citing papers, 2.5% of this breakdownJapan: 323 citing papers, 2.1% of this breakdownAustralia: 308 citing papers, 2% of this breakdownSouth Korea: 296 citing papers, 1.9% of this breakdown
0%20.9%Other 31.4%

Fields

  • Medicine37.1%
  • Biochemistry, Genetics and Molecular Biology27%
  • Neuroscience21.2%
  • Immunology and Microbiology4.6%
  • Agricultural and Biological Sciences2.4%
  • Computer Science1.7%
  • Other6%

Topics

  • Neuroscience and Neuropharmacology Research4.9%
  • Alzheimer's disease research and treatments2.5%
  • Tryptophan and brain disorders2.5%
  • Neuroinflammation and Neurodegeneration Mechanisms2.4%
  • Stress Responses and Cortisol1.7%
  • Computational Drug Discovery Methods1.5%
  • Other84.5%

Coauthors

All papers

Open in search
  1. Natural products in drug discovery: advances and opportunities

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Keith M. Godfrey, Christian W. Gruber, Jag Heer, Lukas A. Huber, Elena Ibáñez, Anake Kijjoa, Anna K. Kiss, Aiping Lü, Francisco A. Macı́as, Mark J.S. Miller, Andrei Mocan, Rolf Müller, Ferdinando Nicoletti, George Perry, Valeria Pittalà, Luca Rastrelli, Michael Ristow, Gian Luigi Russo, A. Sanches‐Silva, Daniela Schuster, Helen Sheridan, Krystyna Skalicka‐Woźniak, Léandros Skaltsounis, Eduardo Sobarzo‐Sánchez, David S. Bredt, Hermann Stuppner, Antoni Sureda, Nikolay Tzvetkov, Rosa Anna Vacca, Bharat B. Aggarwal, Maurizio Battino, Francesca Giampieri, Michaël Wink, Jean‐Luc Wolfender, Jianbo Xiao, Andy Wai Kan Yeung, Gérard Lizard, Michael Popp, Michael Heinrich, Ioana Berindan-Neagoe, Marc Stadler, Maria Daglia, Robert Verpoorte, Claudiu T. Supuran - Nature Reviews Drug Discovery 2021 cited by 5,001

  2. The neuropathic pain: An overview of the current treatment and future therapeutic approaches

    Authors: , , , , - International Journal of Immunopathology and Pharmacology 2019 cited by 479

  3. The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress

    Authors: , , , , , , , , - Current Neuropharmacology 2020 cited by 273

  4. Phytol: A review of biomedical activities

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mohammad S. Mubarak, Siddhartha Kumar Mishra, Jamil A. Shilpi, Atanas G. Atanasov - Food and Chemical Toxicology 2018 cited by 463

  5. Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy

    Authors: , , , , - Journal of Clinical Medicine 2023 cited by 153

  6. Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Aging 2011 cited by 700

  7. GSK-3 as potential target for therapeutic intervention in cancer

    Authors: , , , , , , , , , , , , , , , , , - Oncotarget 2014 cited by 505

  8. Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs

    Authors: , , , , , , , , , , , , , , , , , , , , , - Aging 2017 cited by 281

  9. Metabotropic glutamate receptors: From the workbench to the bedside

    Authors: , , , , , , , - Neuropharmacology 2010 cited by 637

  10. Induction of Dickkopf-1, a Negative Modulator of the Wnt Pathway, Is Associated with Neuronal Degeneration in Alzheimer's Brain

    Authors: , , , , , , , , , - Journal of Neuroscience 2004 cited by 397

  11. β-Amyloid Monomers Are Neuroprotective

    Authors: , , , , , , , , , , , , , - Journal of Neuroscience 2009 cited by 406

  12. Ageing: from inflammation to cancer

    Authors: , , , , - Immunity & Ageing 2018 cited by 235

  13. Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target

    Authors: , , , , , , , , , , , , , , - Pharmacological Research 2018 cited by 175

  14. Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets

    Authors: , , , - European Journal of Pharmacology 2009 cited by 315

  15. Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades Which Alter Therapy Response.

    Authors: , , , , , , , , , , , , , , , , , , , , - Oncotarget 2012 cited by 305

  16. The cytokine network in the pathogenesis of major depressive disorder. Close to translation?

    Authors: , , , , , , , , - Autoimmunity Reviews 2020 cited by 86

  17. Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention

    Authors: , , , , , , , , , , , , , - Leukemia 2013 cited by 252

  18. Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors

    Authors: , , , , , , , , , - Neuropharmacology 2016 cited by 91

  19. Mind the gap: glucocorticoids modulate hippocampal glutamate tone underlying individual differences in stress susceptibility

    Authors: , , , , - Molecular Psychiatry 2014 cited by 199

  20. Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study.

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020 cited by 112

  21. Glymphatic System as a Gateway to Connect Neurodegeneration From Periphery to CNS

    Authors: , , , , , , - Frontiers in Neuroscience 2021 cited by 106

  22. The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway

    Authors: , , , , , , , , , - Clinical Immunology 2022 cited by 24

  23. L -acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 266

  24. Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein

    Authors: , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 512